A case of acute myelitis as a neurological complication of COVID-19

Authors

  • H.V. Palahuta tate Institution of Higher Education “Uzhhorod National University”, Regional Center of Neurosurgery and Neurology, Uzhhorod, Ukraine http://orcid.org/0000-0001-7348-4390
  • S.K. Yevtushenko Kharkiv Medical Academy of Postgraduate Education, Kharkiv, Ukraine

DOI:

https://doi.org/10.22141/2224-0713.16.7.2020.218244

Keywords:

COVID-19, SARS-CoV-2, myelitis, neurological manifestations of COVID-19

Abstract

Pandemic of coronavirus infection 2019 (COVID-19) is associated with severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2). Recent evidence suggests that SARS-CoV-2 exhibits neurotropic properties and causes neurological diseases. Neurological manifestations such as impaired consciousness, stroke and seizures have been reported in patients with COVID-19. However, these manifestations are not necessarily associated with direct infection of the peripheral or central nervous system but may occur secondary to a severe systemic reaction in response to a viral infection outside the nervous system.

References

Mao L., Jin H., Wang M. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020. Vol. 77. № 6. Р. 683-690.

Wu Y., Xu X., Chen Z. et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, Behav., Immun. 2020. № 87. Р. 18-22.

Asadi-Pooya A.A., Simani L. Central nervous system manifestations of COVID-19: a systematic review. J. Neurol. Sci. 2020. № 413. Р. 116832.

Correia A.O., Feitosa P.W.G., Moreira J.L.S. et al. Neurological manifestations of COVID-19 and other coronaviruses: A systematic review. Neurol. Psychiatry Brain Res. 2020. № 37. Р. 27-32.

Zhao K., Huang J., Dai D. et al. Acute myelitis after SARS-CoV-2 infection: a case report. medRxiv. 2020. https://doi.org/10.1101/2020.03.16.20035105.

Sarma D., Bilello L.A. A case report of acute transverse myelitis following novel coronavirus infection. Clinical Practice and Cases in Emergency Medicine. 2020. Vol. 4. № 3. Р. 321-323.

Munz M., Wessendorf S., Koretsis G. et al. Acute transverse myelitis after COVID-19 pneumonia. Journal of Neurology. 2020. № 267. Р. 2196-2197.

Chow C.C.N., Magnussen J., Ip J. et al. Acute transverse myelitis in COVID-19 infection. BMJ Case Rep. 2020. Vol. 13. № 8. e236720

Valiuddin H., Skwirsk B., Paz-Arabo P. Acute transverse myelitis associated with SARS-CoV-2: A Case-Report. Brain Behav. Immun. Health. 2020. № 5. 100091.

Phua J., Weng L., Ling L. et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir. Med. 2020. № 8. Р. 506-517.

Xiang P., Xu X.M., Gao L.L. et al. First case of 2019 novel coronavirus disease with encephalitis. China Xiv. 2020. T202003.00015.

Moriguchi T., Harii N., Goto J. et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020. № 94. Р. 55-58.

Mehta P., McAuley D.F., Brown M. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020. Vol. 395. № 10229. Р. 1033-1034.

Chen X., Laurent S., Onur O.A. et al. A systematic review of neurological symptoms and complications of COVID-19. J. Neurol. 2020. Р. 1-11.

Baig A.M., Khaleeq A., Ali U. et al. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem. Neurosci. 2020. Vol. 11. № 7. Р. 995-998.

Guo J., Huang Z., Lin L. et al. Coronavirus disease 2019 (COVID-19) and cardiovascular disease: A viewpoint on the potential influence of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers on onset and severity of severe acute respiratory syndrome coronavirus 2 infection. J. Am. Heart Assos. 2020. Vol. 9. № 7. e016219.

Zhu Z., Cai T., Fan L. et al. Clinical value of immune-inflammatory parameters to assess the severity of coronavirus disease 2019. Int. J. Infect. Dis. 2020. № 95. Р. 332-339.

Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020. № 395. Р. 1054-1062.

Ruan Q., Yang K., Wang W. et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020. № 46. Р. 846-848.

Published

2020-10-01

Issue

Section

Original Researches